PF-07293893

N/A

Report date: 2024/10/14 17:29:07
NME

Base Information

Drug NamePF-07293893
Drug Alias NamePF-07293893
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action5'-AMP-activated protein kinase subunit gamma-3 inhibitors
Targets5'-AMP-activated protein kinase subunit gamma-3
Therapy Area/IndicationsHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPfizer Pharmaceutical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesPfizer Inc
Inactive CompaniesN/A
Active IndicationsHeart Failure
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A